
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Keywords: Bacteria; Intestine; Metabolomics; Colitis; AEA; arachidoyl ethanolamide; 3AIBA; 3-aminoisobutyric acid; BHIS; brain heart infusion-supplemented; CDI; Clostridium difficile infection; CSA13; cationic steroid antimicrobial 13; FMT; fecal microbiota trans